Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

3(60.0%)

N/A

2(40.0%)

5Total

Phase 2(3)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05404750Recruiting

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

Role: collaborator

NCT06652568Not ApplicableCompleted

Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection

Role: collaborator

NCT03573648Phase 2Active Not Recruiting

Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer

Role: collaborator

NCT06226220Not ApplicableRecruiting

Percutaneous Nerve Evaluation Trial Time

Role: collaborator

NCT05081193Phase 2Completed

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

Role: collaborator

NCT05281809Phase 2Recruiting

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

Role: collaborator

NCT02628379Completed

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

Role: collaborator

All 7 trials loaded